Circulating interleukin-18 (IL-18) as a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.

Author
KARABULUT, Senem
Bilgin, Elif
Karabulut, Mehmet
Tuna, Savas
Alis, Halil
TAŞ, Faruk
Gonenc, Murat
Dagoglu, Nergiz
Afsar, Cigdem Usul
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/176103
https://doi.org/10.1200/jco.2016.34.15_suppl.e15678
Collections